184 related articles for article (PubMed ID: 8623426)
41. Human natural cytotoxic antibodies recognize cross-reactive antigens on pig endothelial cells and pig red blood cells.
Gautreau C; Cardoso J; Zhao Z; Chereau C; Woimant G; Houssin D; Weill B
Transplant Proc; 1994 Jun; 26(3):1397. PubMed ID: 8029956
[No Abstract] [Full Text] [Related]
42. The impact of human ABO blood groups on human xenoreactive antibody-mediated cytotoxicity and the protective effect of human decay-accelerating factors exogene on swine endothelium.
Lee JM; Tu CF; Tai HC; Chou NK; Weng CN; Lee YC; Lee PH
Transplant Proc; 2008 Mar; 40(2):551-3. PubMed ID: 18374126
[TBL] [Abstract][Full Text] [Related]
43. Overlapping recognition of xenogeneic carbohydrate ligands by human natural killer lymphocytes and natural antibodies.
Inverardi L; Clissi B; Stolzer AL; Bender JR; Pardi R
Transplant Proc; 1996 Apr; 28(2):552. PubMed ID: 8623263
[No Abstract] [Full Text] [Related]
44. Species differences in natural xenoantibody to swine.
Fabian MA; Abernethy KA; Bollinger RR
Transplant Proc; 1992 Apr; 24(2):604. PubMed ID: 1566447
[No Abstract] [Full Text] [Related]
45. Human anti-B alloantibodies recognize xenoantigens on pig red blood cells and endothelial cells.
Gautreau C; Woimant G; Grosse H; Cardoso J; Soubrane O; Houssin D
Transplant Proc; 1996 Apr; 28(2):563. PubMed ID: 8623273
[No Abstract] [Full Text] [Related]
46. Potent inhibition of human and baboon anti-alpha Gal antibodies by a subfraction of oligosaccharides derived from porcine stomach mucin.
Li S; Neethling FA; Yeh JC; Cooper DK; Cummings RD
Transplant Proc; 1996 Apr; 28(2):558. PubMed ID: 8623268
[No Abstract] [Full Text] [Related]
47. Xenoreactive natural antibodies and isohemagglutinins: a distinct class of antibodies.
Lin SS; Parker W; Lundberg-Swanson K; Holtzknecht ZE; Platt JL
Transplant Proc; 1996 Apr; 28(2):573. PubMed ID: 8623278
[No Abstract] [Full Text] [Related]
48. Biological activity of pig islet-cell reactive IgG antibodies in xenotransplanted diabetic patients.
Lindeborg E; Kumagai-Braesch M; Tibell A; Christensson B; Möller E
Xenotransplantation; 2004 Sep; 11(5):457-70. PubMed ID: 15303983
[TBL] [Abstract][Full Text] [Related]
49. Removal of anti-Gal alpha (1,3)Gal antibodies diminishes the cytotoxic effect of primate xenoreactive antibodies on rat endothelial cells.
Azimzadeh A; Anegon I; Thibaudeau K; Charreau B; Zibolt P; Cinqualbre J; Soulillou JP; Wolf P
Transplant Proc; 1997 Aug; 29(5):2337. PubMed ID: 9270751
[No Abstract] [Full Text] [Related]
50. The sharing of target-epitopes between human anti-ABO hemagglutinating and anti-Pig (xeno) endothelium or anti-Pig thyroglobulin antibodies.
Morita N; Hagihara M; Kanai N; Hiraga S; Saito A; Sakai H; Tsuji K
Tokai J Exp Clin Med; 2003 Jul; 28(2):71-80. PubMed ID: 14714832
[TBL] [Abstract][Full Text] [Related]
51. Xenoreactivity in the pig islet to human combination: feasibility of adenovirus-mediated gene transfer into pig islets.
Mirenda V; Charreau B; Sigalla J; Cassard A; Huvelin JM; David A; Soulillou JP; Le Mauff B; Anegon I
Transplant Proc; 1996 Apr; 28(2):808-10. PubMed ID: 8623410
[No Abstract] [Full Text] [Related]
52. Thomsen-Friedenreich and PK antigens in pig-to-human xenotransplantation.
Cairns T; Lee J; Goldberg LC; Hakim N; Cook T; Rydberg L; Samuelsson B; Taube D
Transplant Proc; 1996 Apr; 28(2):795-6. PubMed ID: 8623404
[No Abstract] [Full Text] [Related]
53. Pig islet xenoantigens recognized by human preformed natural antibodies: a preliminary definition.
Inverardi L; Clissi B; Sanvito F; Fazi C; Ricordi C; Pardi R
Transplant Proc; 1997 Jun; 29(4):2260-1. PubMed ID: 9193616
[No Abstract] [Full Text] [Related]
54. In vitro investigation of pig cells for resistance to human antibody-mediated rejection.
Hara H; Long C; Lin YJ; Tai HC; Ezzelarab M; Ayares D; Cooper DK
Transpl Int; 2008 Dec; 21(12):1163-74. PubMed ID: 18764834
[TBL] [Abstract][Full Text] [Related]
55. Lack of antibody production against Hanganutziu-Deicher (H-D) antigens with N-glycolylneuraminic acid in patients with porcine exposure history.
Kobayashi T; Yokoyama I; Suzuki A; Abe M; Hayashi S; Matsuda H; Morozumi K; Breimer ME; Rydberg L; Groth CG; Tibell A; Korsgren O; Takagi H; Nakao A
Xenotransplantation; 2000 Aug; 7(3):177-80. PubMed ID: 11021662
[TBL] [Abstract][Full Text] [Related]
56. Oxidant stress increases susceptibility of porcine endothelial cells to injury by xenoreactive antibody and complement.
Magee JC; Platt JL; Oldham KT; Guice KS
Transplant Proc; 1994 Jun; 26(3):1170. PubMed ID: 8029874
[No Abstract] [Full Text] [Related]
57. Characterization of the human alpha 1,3Gal-reactive natural antibody population.
McMorrow IM; Comrack C; Sachs DH; Monroy R; DerSimonian H
Transplant Proc; 1996 Apr; 28(2):547. PubMed ID: 8623259
[No Abstract] [Full Text] [Related]
58. New World monkeys as a primate model for xenografts in the absence of anti-Gal.
Galili U; Gregory CR; Morris RE
Transplant Proc; 1996 Apr; 28(2):567-8. PubMed ID: 8623275
[No Abstract] [Full Text] [Related]
59. Enzymatic removal from various tissues of the galactose alpha 1,3-galactose target antigens of human antispecies antibodies.
Cairns T; Hammelmann W; Gray D; Welsh K; Larson G
Transplant Proc; 1994 Jun; 26(3):1279-80. PubMed ID: 7518125
[No Abstract] [Full Text] [Related]
60. Inhibition of primates performed xenoantibody binding to pig aortic endothelial cells and its potential application to xenotransplantation.
Kwiatkowski P; Mazurek AP; Rowiński W; Fiedor P
Acta Pol Pharm; 1997; 54(1):43-7. PubMed ID: 9415198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
